INSIGHTS ON SOLID DOSE MANUFACTURING
-
Shaping The Future Of Solid Dose Manufacturing With Hot Melt Extrusion
Enhance your drug development strategies today and master hot melt extrusion by learning about excipient selection, equipment setup, novel screening tools, and process optimization.
-
Understanding Aseptic Powder Filling: Key Principles And Techniques
Pharmaceutical production of sterile powders presents unique hurdles. Explore the core principles and advanced techniques vital for aseptic filling, from containment to precise dosage control.
-
Navigating OSD Formulation Development And Leveraging CDMO Partnership
Collaborating with an experienced CDMO can provide the expertise and facilities needed to navigate oral solid dose formulation complexities and ensure compliance with regulatory frameworks.
-
Maximize Uptime And Yield With This Feeder Base Leveling System
Learn how a patented leveling system provides real-time, three-gauge feedback, ensuring precision, maximizing uptime, and protecting your critical production equipment.
-
Orally-Disintegrating Dosage Forms With Taste Masked Multiparticulates7/17/2024
Learn more about our orally disintegrating tablet (ODT) capabilities and how these innovative technologies have the potential to improve acceptance, adherence, and compliance in pharmacotherapy.
-
Less Mess, Less Stress, Best Expressed: An Alternative To Spray Drying7/16/2024
Although well-established processes, spray drying and hot-melt extrusion can be outperformed in bioavailability, cost-savings, manufacturing speed, environmental impact, and more.
-
Softgel Formulation: Addressing Stability, Shelf-Life, And Bioavailability5/16/2024
A CDMO that has expertise and resources in softgel formulation can help companies address stability issues, improve drug bioavailability, or ensure compliance with regulations.
-
The Importance Of Tablet Density Uniformity10/7/2025
Non-uniform density causes many tablet failures. Learn how optimizing your formulation, tablet proportions, and tooling design ensures proper de-aeration for consistent quality.
-
Tablets And Capsules: Overcoming Similar Obstacles In Production7/30/2024
Explore how understanding specific USP chapters can address common tablet and capsule production challenges and ensure high-quality results in this essential pharmaceutical process.
SOLID DOSE MANUFACTURING SOLUTIONS
-
This high-output, vacuum drum commercial platform forms part of our Evolve range, designed to fill blister strips at high-speed. This unit offers a commercial scale-up from our vacuum drum development platform.
-
Used O'Hara LabCoat bench-top coating pan, model LABCOAT BT, stainless steel product contact surfaces, with 8.5" perforated pan with plenum, spray guns with Watson Marlow peristaltic pump system, on board air handling system, electrically heated, Siemens controls, 220 volt, 1 phase, 60 hertz, serial# 414, built 2015.
-
Mettler XS204 Powder Weighing Enclosure designed to provide personnel protection when working with powdered substances down to a respiratory exposure concentration of less than 1 microgram powder per cubic meter of air (<1 ug/m3). Design accommodates sufficient space for efficient, ergonomic execution of powder weighing operations utilizing the Mettler XS204 Analytical Balance with dimensions (DxHxW) of 17.84” x 12.67” x 10.35” [453mm x 322mm x 263mm].
-
Natoli Engineering is quickly becoming the leader in R&D tablet presses with this next-generation rotary tablet press. Designed to help solve formulation and scale-up challenges, the NP-RD30 rotary R&D tablet press replicates the design and functionality of a production press. The turret velocity of the NP-RD30 can reach that of production presses, meaning dwell time can be more accurately established during research and development.
-
Partner with Natoli Scientific during the earliest stages. Our scientific expertise with state-of-the-art analytical capabilities is ready to take any preformulation challenge.
Natoli scientific has an expertise of handling a wide range of APIs for the development of oral solids. We apply principles of ‘Quality by Design’ to define Critical Material Attributes (CMA), Critical Process Parameters (CPP), Critical Quality Attributes (CQA) and Quality Target Product Profiles (QTPP). Because we believe that understanding material and process as much as possible in the early life cycle of drug product development program is an insurance for further development path. Keeping your practices up to date with the ICHQ8 regulatory guidance issued by the US FDA. This is also a gate way for a smooth ride of product in the different stages of product development stages.